• portrait of Anibal Chertcoff
  • Assistant professor

    Max Rady College of Medicine
    Internal Medicine
    Section: Neurology
    University of Manitoba
    Room GB-409 – 820 Sherbrook Street
    Health Sciences Centre Winnipeg
    Winnipeg, Manitoba R3A 1R9

    204-787-3938
    anibal.chertcoff@umanitoba.ca

Cross appointments

Does not hold any cross-appointments.

Research achievements

Research summary

Dr. Anibal Chertcoff’s research focuses on understanding the relationship between multiple sclerosis (MS) and psychiatric disorders. He explores the early stages of MS, aiming to identify psychiatric symptoms that may precede the disease onset. 

His work integrates large-scale epidemiological studies and advanced data analytics to examine the intersection of neurological and psychiatric disorders in patients with MS and other demyelinating diseases.

  • Keywords

    • data analytics
    • demyelinating diseases
    • early diagnosis
    • epidemiology
    • multiple sclerosis
    • psychiatric comorbidity
  • Research affiliations

  • Research groups

    Co-investigator, CANOPTICS: Canadian Neuromyelitis Optica Spectrum Disorder (NMOSD) and other atypical demyelinating diseases Cohort Study

Biography

Brief bio

Dr. Anibal Chertcoff is a neurologist and psychiatrist from Argentina, specializing in multiple sclerosis (MS) and related neurological conditions. He has developed a solid foundation in clinical practice and research, particularly in the areas of MS epidemiology and psychiatric comorbidities.

Dr. Chertcoff completed a clinical fellowship in MS at the BARLO MS Centre, St. Michael’s Hospital, University of Toronto. This fellowship allowed him to gain extensive experience in managing complex MS cases. Prior to this, he served as a postdoctoral fellow in the Pharmacoepidemiology in MS group at the University of British Columbia, working under the supervision of Prof. Helen Tremlett. His research during this time focused on the MS prodrome, psychiatric comorbidities in MS, and the impact of polypharmacy on MS patients.

Throughout his career, Dr. Chertcoff has held positions at respected institutions, including his role as an MS neurologist at the Hospital Británico de Buenos Aires, in Argentina. He has been involved in various research projects, receiving support from organizations such as MS Canada, the MS International Federation, and Michael Smith Health Research BC.

Education

  • Clinical Fellowship in Multiple Sclerosis, BARLO MS Centre, St. Michael’s Hospital, University of Toronto (2022-2023)
  • Postdoctoral Research Fellow, Pharmacoepidemiology in MS Group, University of British Columbia (2021-2023)
  • Clinical Fellowship in Multiple Sclerosis, Hospital Británico de Buenos Aires, Argentina (2018-2019)
  • Neurology Residency, Hospital Británico de Buenos Aires, Argentina (2015-2018)
  • PGY-1 in Internal Medicine (Neurology Residency), Hospital Fernández, Buenos Aires, Argentina (2014-2015)
  • Psychiatry Residency, Hospital Alvear, Buenos Aires, Argentina (2010-2014)
  • Medical Degree (Honors Diploma), Universidad Maimónides, Faculty of Health Sciences, Buenos Aires, Argentina (2004-2010)

Awards

2021-2023: 

  • Multiple Sclerosis Society of Canada’s endMS Postdoctoral Fellowship

2021-2023: 

  • Michael Smith Foundation for Health Research – Trainee Award

2018: 

  • Multiple Sclerosis International Federation Du Pré Grant

Contact us

Internal Medicine
Room GC430, Health Sciences Centre
820 Sherbrook Street
University of Manitoba
Winnipeg, MB R3A 1R9 Canada

204-787-7772
204-787-4826